Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neu Base Therapeutics Inc
(NQ:
NBSE
)
1.000
+0.040 (+4.17%)
Streaming Delayed Price
Updated: 12:46 PM EDT, May 27, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
65,864
Open
1.040
Bid (Size)
0.9800 (17)
Ask (Size)
1.000 (45)
Prev. Close
0.9600
Today's Range
0.9800 - 1.040
52wk Range
0.8900 - 5.510
Shares Outstanding
32,258,657
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...
Via
Benzinga
Lannett And 4 Other Penny Stocks Bought By Insiders
March 22, 2022
US stock futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Performance
YTD
-66.10%
-66.10%
1 Month
-27.01%
-27.01%
3 Month
-25.37%
-25.37%
6 Month
-67.74%
-67.74%
1 Year
-80.81%
-80.81%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 16, 2022
Via
Benzinga
Single Dose Of NeuBase's Lead Program Shows Encouraging Preclinical Studies
March 14, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
Via
Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 31, 2021
Via
Benzinga
5 Stocks To Watch For December 27, 2021
December 27, 2021
Via
Talk Markets
5 Stocks To Watch For December 27, 2021
December 27, 2021
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
Via
Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
July 14, 2021
Via
Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
July 07, 2021
Via
Benzinga
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
July 07, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 06, 2021
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.